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LUNDQUIST, C. T., F. L. CLOTTENS, G. M. HOLMAN, R. NICHOLS, R. J. NACHMAN AND D. R. NJkSSEL. Callitachykinin 
1 and II, two novel myotropic peptides isolated from the blowfly, Calliphora vomitoria, that have resemblances to tachykinins. 
PEPTIDES 15(5) 761-768, 1994.--Two peptides, related to the locust myotropic peptides locustatachykinin I-IV, were isolated 
from the blowfly Calliphora vomitoria. Whole, frozen flies were used for extraction with acidified methanol. A cockroach hindgut 
muscle contraction bioassay was used for monitoring fractions during subsequent purification steps. A series of eight different 
high performance liquid chromatography column systems was required to obtain optically pure peptides. Two peptides were 
isolated and their sequences determined by Edman degradation and confirmed by mass spectrometry and chemical synthesis as 
APTAFYGVR-NH2 and GLGNNAFVGVR-NH2. They were named callitachykinin I and II. The peptides have sequence sim- 
ilarities to the locustatachykinins and vertebrate tachykinins. Both callitachykinins were recognized by an antiserum to locusta- 
tachykinin I in enzyme-linked immunosorbent assay (ELISA) tests and callitachykinin II was additionally recognized by an 
antiserum to the vertebrate tachykinin kassinin, suggesting that immunolabeling of blowfly neurons with these antisera is due to 
neuronal callitachykinins. 
Tachykinins Calliphora vomitoria Insect neuropeptide Insect nervous system Locustatachykinin 
RECENTLY four myotropic neuropeptides with some sequence 
homology to vertebrate tachykinins were isolated from extracts 
of the brain and the corpora cardiaca-corpora allata complex 
of the locust Locusta migratoria. These peptides were named 
locustatachykinins I-IV [LomTK I-IV; (6,33,34)]. Together with 
eledoisin, a tachykinin isolated from the salivary glands of the 
cephalopod Eledone (11), urechistachykinin I and II; isolated 
from the echiuroid worm, Urechis unicinctus (19) and sialokinin 
I and II, isolated from the salivary glands of the mosquito Aedes 
aegypti (2), the LomTKs were to date the only identified inver- 
tebrate representatives of this large peptide family. In the locust, 
Locusta migratoria, these peptides stimulate the contraction of 
the oviduct and foregut (33,34). Additionally, locustatachykinins 
stimulate pheromonotropic activity in the pheromone glands of 
the moth Bombyx mori (13). In the blowfly several, clearly dif- 
ferent, neuron populations contain material reacting with an- 
tisera raised against different tachykinins, including LomTK I 
(24,25,31,32). The distribution of the immunoreactive material 
indicates that native tachykinin-related neuropeptides may act 
as neurotransmitters or neuromodulators in interneuronal cir- 
cuits in the blowfly central nervous system. LomTK-like im- 
munoreactivity was, in addition, found in intrinsic endocrine 
cells of the blowfly midgut (25). 
To establish some of the functional roles of the tachykinin- 
related peptides in the blowfly, it is necessary to determine the 
primary structures of the native neuropeptides. Here we describe 
the purification and isolation of two novel myotropic, tachykinin- 
related peptides from blowfly tissue extract. We employed the 
cockroach hindgut contraction bioassay, earlier used during the 
isolation of cockroach, locust, and cricket myotropic peptides (l 8), 
i Requests for reprints should be addressed to Dick R. Nfissel. 
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to monitor the blowfly peptides during purification. The two myo- 
tropic peptides isolated and characterized from Calliphora vomitoria 
extracts are also recognized in a LomTK ELISA. The novel peptides 
were named callitachykinin I and II. 
METHOD 
Animals and Tissue Extraction 
Pupae of the blowfly Calliphora vomitoria were purchased 
from EKOL AB (Link6ping, Sweden). After hatching the flies 
were collected, frozen, and stored at - 80°C  until further pro- 
cessing. The rearing of the cockroach Leucophaea maderae, the 
hindgut preparation, and bioassay are described in detail else- 
where (5,15,18). A total of 3.6 kg blowflies (about 90,000 whole 
specimens) was used for extraction. Batches of 120 g frozen flies 
were extracted in 1200 ml methanol:water:acetic acid (90:9:1). 
The flies were homogenized in cold extraction solvent with a 
Polytron® homogenizer. The homogenate was centrifuged at 
8000 X g for 30 min at 4°C. The supernatant was filtered through 
two nylon filter membranes (5/~m and 1.2 t~m; Poretics Inc., 
Livermore, CA) placed on top of each other. The filtrate was 
saved. The pellet was resuspended in 1200 ml fresh extraction 
solvent, and centrifuged and filtered as above. The filtrates were 
mixed and diluted in 1% trifluoroacetic acid (TFA; Sigma, St. 
Louis, MO) in water to a final concentration of 4:1 of filtrate 
and 1% aqueous TFA and centrifuged (5500 X g for 30 min at 
4°C). After centrifugation, the supernatant was filtered through 
an activated and equilibrated Mega Bond Elut c~ C 18 cartridge 
(60 ml, 10 g; Varian, Harbour City, CA). After an initial wash 
with 50 ml of a 4:1 mixture of extraction solvent and 1% aqueous 
TFA, the filtrate was passed through the column. The eluate 
was concentrated by rotary evaporation (removal of methanol) 
and the remainder was applied to an activated and equilibrated 
CI 8 Sep-Pak-Vac® cartridge (35 ml, 10 g; Waters/Millipore, 
Milford, MA). After the extract was bound to the cartridge it 
was washed with 100 ml 0.1% aqueous TFA in water. Subse- 
quently, the extract was eluted with 50 ml each of 10%, 30%, 
50%, and 80% acetonitrile (Merck, Darmstadt, Germany) con- 
taining 0.1% aqueous TFA. Tissue (60 g equivalents) was loaded 
onto the cartridge for each run for a total of 60 runs. Aliquots 
of the different eluates (representing 1 g of blowfly tissue) were 
tested for bioactivity in the Leucophaea hindgut contraction 
bioassay. The acetonitrile of the different fractions was removed 
by rotary evaporation and the remainder was freeze-dried until 
further use. 
Purification and Isolation Procedures 
Isolation was performed on a Waters ALC 100 high perfor- 
mance liquid chromatograph equipped with two pumps, a sol- 
vent programmer, a Rheodyne septumless injector, and a vari- 
able wavelength detector. The peptide material was sequentially 
eluted through eight different column systems. Aliquots, rep- 
resenting 1-5% of each fraction, were tested on the hindgut con- 
traction bioassay and the fractions containing myotropic activity 
were further processed through the next column. The columns 
and the operating conditions were: 
(a) Waters Delta Pak C 18,300 ~,, 15 tsm, 25 X 100 mm (Waters 
Assoc., Milford, MA). Solvent A: 0.1% TFA in water; solvent 
B: 50% acetonitrile in 0.1% aqueous TFA. Conditions: a 
linear gradient from 0-100% B over 150 min; flow rate 7.5 
ml/min; 15-ml fractions were collected every 2 min; detector 
set at 2.0 absorption units full scale (AUFS) at 214 nm. 
(b) Waters Delta Pak C4, 300 A, 15 #m, 25 X 100 mm (Waters). 
Conditions as for (a). 
(c) Vydac Phenyl, 300 A, 5 um, 10 X 250 mm (Phenomenex, 
Torrance, CA). Solvents and gradient as for (a); flow rate 2 
ml/min; 4-ml fractions were collected every 2 min; detector 
set at 4.0 AUFS at 214 nm. 
(d) Waters Nova Pak C8, 100 ~., 4 #m, 8 X 100 mm (Waters). 
Solvents and gradient as for (a); flow rate 1.5 ml/min; 3-ml 
fractions were collected every 2 min; detector set at 2.0 AUFS 
at 214 nm. 
(e) Vydac Diphenyl, 100 ~,, 4.6 X 250 mm (Phenomenex). 
Conditions as for (a). 
(f) Spherex C18 3-ODS, 4.6 X 150 mm (Phenomenex). Solvents 
as in (a); flow rate 1.0 ml/min; peaks collected manually; 
detector set at 0.5 AUFS at 214 nm. 
(g) 1-125 Waters Protein Pak, 7.8 X 300 mm (Waters). Solvent 
A: 95% acetonitrile in 0.01% aqueous TFA; solvent B: 50% 
acetonitrile in 0.01% aqueous TFA. Conditions: 100% A for 
8 rain, then a linear gradient of 0-100% B over 80 min; flow 
rate 1.5 ml/min; peaks collected manually; detector set at 
0.2 AUFS at 214 rim. 
(h) The last purification step was performed on an Applied Bio- 
systems Microbore HPLC, consisting ofa 140B solvent de- 
livery system and a 785A programmable absorbance detec- 
tor. It was equipped with a Progel~-TSK C 18 NPR column, 
4.6 X 35 mm (Supelco, Bellefonte, PA). Solvents: same as 
for (a). Conditions: 100% A for 3 min, then a linear gradient 
of 0-100% B over 50 min; flow rate 100 ~l/min; peaks were 
collected manually; detector set at 0.1 AUFS at 214 nm. 
Enzymatic Degradation 
Dried aliquots of 1-3% of each isolated peptide were taken 
up in 200 tal cockroach saline and incubated with one unit of 
immobilized aminopeptidase M gel suspension (Pierce, Rock- 
ford, IL). As a control, an identical set of peptides was taken up 
in saline only. The mixtures were shaken in a 37°C water bath 
for 2 h. The gel was removed from the suspension by centrifu- 
gation and the supernatant was transferred directly to the hindgut 
bioassay chamber. 
Amino Acid Sequence Analysis, Peptide Synthesis', and Mass 
Spectrometry 
The amino acid sequence of the two isolated peptides was 
determined with an Applied Biosystems model 473A automated 
protein sequencer with on-line detection of PTH-amino acids 
using standard operating conditions. Approximately 100 pmol 
of each peptide was used for the analysis. The masses of the 
natural peptides were determined using laser desorption mass 
spectrometry on a Vestec model 2000 laser desorption time-of- 
flight mass spectrometer. Samples were run in a positive mode 
using c~-cyano-4-hydroxycinnamic acid as the matrix. Mass ac- 
curacy is generally 0.05% or better. Calculated average masses 
were determined using the computer program PROCOMP ver- 
sion 1.2. This program was developed by P. C. Andrews, PhD, 
University of Michigan, for peptide data manipulations on IBM- 
compatible computers. 
Based on the structural information obtained from the se- 
quence analysis, the two peptides were synthesized by the solid- 
phase peptide synthesis on a Vega coupler 250 automated peptide 
synthesizer using Fmoc chemistry with diisopropylcarbodiimide 
as the coupling reagent and dimethylformamide as solvent. The 
structural identity of the synthetic peptides was confirmed by 
the presence of the molecular ions (MH +) in the mass spectra 
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taken on a VG-70-250 EHF spectrometer (VG Analytical, Man- 
chester, UK) according to previously described procedures (28). 
The synthetic peptides were also analyzed by amino acid com- 
position (Table 4) as described earlier (27). 
To compare the retention times of the synthetic peptides with 
the respective natural peptides, a mixture of an equal amount 
of both synthetic and natural peptides were co-chromatographed 
on the following analytical HPLC columns: 
(a) Bi0Sep Sec-S2000, 7.8 x 300 mm (Phenomenex). Solvent 
A: 95% acetonitrile in 0.01% aqueous TFA; solvent B: 50% 
acetonitrile in 0.01% aqueous TFA. Conditions: 100% A for 
8 min, then a linear gradient 0-100% B over 80 rain; flow 
rate 1.5 ml/min; detector set at 0.1 AUFS at 220 nm. 
(b) Vydac Diphenyl, 100 A, 4.6 X 250 mm (Phenomenex). Sol- 
vent A: 0.1% aqueous TFA; solvent B: 60% acetonitrile in 
0.1% aqueous TFA. Conditions: a linear gradient from 0-  
100% B over 120 min; flow rate 1.5 ml/min; detector set at 
0.1 AUFS at 220 nm. 
(c) Spherex C18 3-ODS, 4.6 × 150 mm (Phenomenex). Same 
solvents and conditions as (b); flow rate t.0 ml/min. 
(d) Deltabond C8, 5 #m, 4.6 X 250 mm (Keystone, Bellefonte, 
PA). Same solvents and conditions as (b). 
(e) Progel~-TSK C18 NPR, 4.6 X 35 mm (Supelco). Same 
solvents and conditions as described above. 
Threshold Concentrations 
The quantity of synthetic peptide was calculated from the 
value obtained for the phenylalanine in the amino acid analysis. 
The quantity of natural peptide was calculated from a standard 
series of known quantities of synthetic peptide on a Vydac Di- 
phenyl column with conditions described for the control of the 
synthetic peptides. Threshold concentrations were determined 
by adding known quantities of synthetic and natural peptide to 
the bioassay chamber containing the Leucophaea hindgut. The 
threshold concentration is defined as that concentration of pep- 
tide that is required to evoke an observable change in frequency, 
amplitude, or tonus of the spontaneous contractions within 1 
min. For each peptide the respectively natural and synthetic 
peptides were tested on the same hindgut preparation. The 
threshold was determined from five different hindgut prepara- 
tions. 
Enzyme-Linked lmmunosorbent Assay 
Enzyme-linked immunosorbent assay (ELISA) was used 
qualitatively to test whether the isolated peptides reacted with 
either of two different tachykinin antisera: one to the frog tachy- 
kinin kassinin (36) and one to locustatachykinin I [LomTK I; 
(25,29)]. The ELISA procedure, using these antisera, is de- 
scribed elsewhere (25). Briefly, the tests were performed as non- 
competitive ELISAs with the LomTK I antiserum diluted l: 
2000 and the kassinin antiserum diluted 1:500. One percent 
aliquots of the purified peptides were coated to the plate (poly- 
styrene MaxiSorp microtiter plates; Nunc, Denmark) and as- 
sayed using both antisera. Furthermore, 5% aliquots of all re- 
maining fractions from the first HPLC column (Delta Pak C18) 
were also checked in the ELISAs for immunoreactivity. 
Finally, an ELISA with a dilution series of the antiserum was 
run on the synthetic peptides. In this case, the LomTK I anti- 
serum was diluted from I:1000 up to 1;100,000 with 10 pmol 
of the peptide coated to the plate. The kassinin antiserum was 
diluted from 1:500 up to 1:50,000 with 100 pmol peptide coated. 
Each test was performed in duplicate. 
RESULTS 
The different acetonitrile fractions that eluted from the Sep- 
Pak cartridges during the initial extraction were tested for myo- 
tropic bioactivity on the cockroach hindgut. Stimulatory effect 
was detected exclusively in the 30% acetonitrile fraction. The 
spontaneous activity was reestablished after rinsing the incu- 
bation chamber. The 10% and 50% fractions showed inhibitory 
effects on the spontaneous activity of the hindgut. The 30% frac- 
tion was taken for further purification. The subsequent sepa- 
ration and purification required eight different HPLC column 
systems. For each system, aliquots of 1-5% of the collected frac- 
tions were screened for myotropic activity on the cockroach 
hindgut. The 30% acetonitrile fraction, representing a total of 
3.6 kg blowfly extract, was divided into eight sets and run sep- 
arately on the first column. Myotropic bioactivity was detected 
in two regions with retention times of 58-61 and 62-65 rain, 
respectively. The material eluting in these time ranges was further 
processed separately through all the other columns. The chro- 
matograms of the first five preparative column systems yielded 
a multitude of UV absorbing peaks (data not shown). The elution 
times for the myotropic material in each column system are 
given in Table 1. The chromatograms of the last three column 
systems are shown in Fig. 1. 
On the final column (Progel TSK C18), two pure peptides 
eluted at 13.5 and 15.0 rain, respectively. To determine whether 
these peptides were N-terminally blocked or not, aliquots were 
treated with the peptide degradation enzyme aminopeptidase 
M for 2 h at 37°C. The bioactivity was measured in the hindgut 
bioassay. No activity could be found for either of the two peptides 
incubated with the enzyme. As a control, aliquots of the peptides 
were incubated in saline for 2 h at 37°C. No loss of the myotropic 
bioactivity was found in the control conditions. 
Aliquots of both peptides, representing approximately 100 
pmol, were sequentially degraded with the gas-phase sequencer. 
The estimation of the aliquots of both peptides was based on 
the absorption characteristics of 100 pmol of a presumed similar 
synthetic peptide (LomTK I) applied on the final column (Progel 
TSK C18), used for the purification of the callitachykinins. 
TABLE 1 
ELUTION TIMES OF MYOTROPIC MATERIAL 
DURING PURIFICATION 
Retention Time (min) 
C o l u m n  Callitachykinin 1 Canitachykinin I1 
Delta Pak C 18 58-61 62-65 
Delta Pak C4 56-57 58-59 
Vydac Phenyl 50-51 52-55 
Nova Pak C8 52-53 54-59 
Vydac Diphenyl 38-39 40-45 
Spberex CI8 53.2 56.7 
1-125 Protein Pak 39.6 43.4 
Progel TM TSK C 18 13.5 15.0 
The table shows the retention times of the myotropic peptide 
material as it eluted on the different columns on HPLC. On the 
first column, the myotropic material eluted in two zones with 
retention times of 58-61 min and 62-65 rain, respectively. The 
retention times of the myotropic material, during the different 
purification steps, can be followed by reading vertically. UV pro- 
files from the three last column systems are illustrated in Fig. t. 
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FIG. 1. Separation and purification of callitachykinin I (A) and II (B). The UV profiles represent the three last HPLC column systems: 
Spherex C18, 1-125 Protein Pak, and Progel TSK C18 microbore. Peaks were collected manually and aliquots were tested in the hindgut 
contraction assay. The x-axes represent the retention times in minutes and the y-axes the percent UV response at different absorption units 
full scale (AUFS), as measured at 214 nm. Callitachykinin I eluted at 53.2 min (indicated by arrow) on the Spherex column and the material 
was pure on the two following columns (final column: 13.5 min). Callitachykinin II eluted at 56.7 min on the Spherex column and the 
material was pure on the two following columns (final column: 15.0 min). 
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TABLE 2 
AUTOMATED EDMAN SEQUENCING: AMINO ACID YIELDS OF 
NATURAL CALLITACHYKININ I AND II* AT EACH STEP 
Amount 
Cycle Number Amino Acid Residue Assignment (pmol) 
Callitachykinin I 
l A (Ala) 143 
2 P (Pro) 75 
3 T (Thr) 41 
4 A (Ala) 83 
5 F (Phe) 75 
6 Y (Tyr) 75 
7 G (Gly) 68 
8 V (Val) 79 
9 R (Arg) 38 
Callitachykinin I1 
1 G (Gly) 17.5 
2 L (Leu) 13.6 
3 G (Gly) 14.1 
4 N (Asn) 11.8 
5 N (Asn) 10.1 
6 A (Ala) 7.1 
7 F (Phe) 4.8 
8 V (Val) 1.7 
9 G (Gly) 5.9 
10 V (Val) 1.2 
11 R (Arg) 1.7 
* Twenty percent of the sample (approximately 20 pmol) was used 
for sequence analysis of callitachykinin II. 
HPLC analysis of  the P T H - a m i n o  acid generated in each cycle 
yielded the following pr imary  sequences: l - - (pep t ide  eluting at 
13.5 min  on Progel TSK C18 co lumn)  Ala-Pro-Thr-Ala-Phe- 
Tyr-Gly-Val-Arg, and  2- - (pept ide  eluting at 15.0 min)  Gly-Leu- 
Gly-Asn-Asn-Ala-Phe-Val-Gly-Val-Arg.  No other  amino  acids 
were detected dur ing  sequencing. The  amino  acid yields of  the 
sequencing are listed in Table 2. The  peptides were assumed to 
be C-terminally amidated  because locustatachykinins  and  ure- 
chis tachykinins  are C-terminally admidated.  The  amino  acid 
sequences were confirmed by mass spectrometry (Table 3). The  
TABLE 3 
MASS SPECTROMETRY OF NATURAL AND SYNTHETIC 
CALLITACHYKININ I AND II 
Observed Molecular Ion 
Calculated Mass (MH+)t 
for (MH+) * 
Peptide (g/mol) Natural Synthetic 
Callitachykinin I 981.1 982.4 980.8 
Callitachykinin II 1103.3 1104.4 1103.2 
* The calculated molecular mass represents the theoretical value and 
includes an amidated C-terminus (NH2). The molecular weights are based 
on monoisotopic amino acids. 
t The natural-occurring peptides were analyzed by laser desorption 
mass spectrometry and the synthetic peptide masses were determined 
by fast atom bombardment mass spectrometry. Positively charged mo- 
lecular ions were analyzed. The observed weights correspond to the mo- 
lecular weight plus one mass unit for hydrogen. 
TABLE 4 
AMINO ACID COMPOSITION ANALYSIS OF SYNTHETIC 
CALL1TACHYKININ I AND II 
Callitachykinin I Callitachykinin II 
( A P T A F Y G V R )  (GLGNNAFVGVR)  
Gly: 6.2 nmol = 1 X G 
Arg: 6.0 nmol = 1 X R 
Thr: 5.3 nmol = 1 X T 
Ala: 10.7 nmol = 2 X A 
Pro: 6.0 nmol = 1 X P 
Tyr: 6.5 nmol = 1 X Y 
Val: 5.3 nmol = 1 X V 
Phe: 6.0 nmol = 1 X F 
Asx: 5.7 nmol = 2 X N or D 
Gly: 9.7 nmol = 3 X G 
Arg: 2.9 nmol = 1 X R 
Ala: 3.0 nmol = 1 × A 
Val: 5.6 nmol = 2 X V 
Leu: 3.0 nmol = 1 X L 
Phe: 2.9 nmol = 1 X F 
two peptides are n a m e d  call i tachykinin I and  II (referring to the 
genus n a m e  Calliphora) in accordance with other  identified in- 
vertebrate tachykinin-l ike peptides. 
Synthetic cal l i tachykinin I and  II were compared  to the nat- 
ural peptides. Co-chromatography of  an  equal mixture of  natural  
and  synthetic peptides on  five different H P L C  co lumns  revealed 
that  they bo th  eluted in one single peak on  each co lumn  system. 
This indicates that,  for both  callitachykinin I and  II, the structures 
of  the natural  and  amidated  synthetic peptides are identical (in- 
cluding a C-terminal  amida t ion  of  the natural  peptides). The  
masses of  the synthetic peptides, as revealed by mass spectrom- 
etry, are shown in Table 3. The  calculated masses (MH +) of  the 
peptides are based on  the molecular  weight of  the monoiso topic  
forms of  amino  acids; cai l i tachykinin I (C46H70N13Ol l) 981.1 g/ 
tool, and  cal l i tachykinin II (C48Ha0N170,3) 1103.3 g/mol.  
For  bo th  peptides the threshold concent ra t ion  to cause an  
increase in the spontaneous  contrac t ion of  the Leucophaea 
hindgut  was de te rmined  (Table 5 and  Fig. 2). Threshold  con- 
centrations for each natural  peptide and  their  respective synthetic 
analogue were nearly identical. This  also indicates tha t  the nat- 
ural peptides are C-terminally amidated,  because the synthetic 
peptides were also. The  a m o u n t  of  natural  product  obta ined for 
each peptide was determined.  For  cal l i tachykinin I a total  of  
3.499 nmol  was recovered after purification out  of  a total  of  
90,000 flies. For  cal l i tachykinin II a total  of  1.837 nmol  was 
A B 
f f 
FIG. 2. Typical response of the isolated hindgut of the cockroach Leu- 
cophaea maderae to (A) 6.5 X l0 - '° M of callitachykinin II natural 
product, and (B) 6.5 × l0 -t° M of callitachykinin II synthetic product. 
The arrows indicate addition ofpeptide. Vertical calibration = 500 mmHg 
displacement; horisontal time mark = 1 min. 
766 LUNDQUIST ET AL. 
TABLE 5 
THRESHOLD CONCENTRATIONS OF NATURAL 
AND SYNTHETIC CALLITACHYKININ I AND II 
IN THE Leucophaea HINDGUT ASSAY 
Threshold Concentration 







1.19 + 0.41 × 10 -9 M 
1.27 ___ 1.04 × 10 -9 M 
3.60 + 2.68 × 10 -~° M 
3.72 + 2.73 × 10 -l° M 
recovered. Therefore, each fly contains 38.9 fmol or 38.2 pg of 
callitachykinin I and 20.4 fmol or 22.5 pg callitachykinin II. 
Aliquots of natural callitachykinin I and II were tested in 
ELISA with an antiserum to locustatachykinin I (LomTK I). 
Both peptides reacted with a maximum response. In the kassinin 
ELISA, only callitachykinin II gave a positive immunoreaction 
under the described conditions. Aliquots from all remaining 
fractions from the first three HPLC column systems (excluding 
fractions containing the bioactive material) were also tested in 
the LomTK I and kassinin ELISAs. No immunoreaction was 
detected. The synthetic caUitachykinin I and II react very similar 
to LomTK I in the ELISA with the LomTK I antiserum. In our 
test system, only callitachykinin II was recognized by the kassinin 
antiserum (Fig. 3). 
DISCUSSION 
In the present study we have described the purification and 
isolation of two novel myotropic peptides from the blowfly Cal- 
liphora vomitoria. By a heterologous muscle contraction bioas- 
say, using the hindgut of the cockroach Leucophaea maderae 
(16), myotropic peptide material was detected and followed 
through a series of different HPLC column systems until chro- 
matographically pure peptides were obtained. The two peptides 
were named callitachykinin I and II. In addition to the bioassay, 
the isolated peptides were also analyzed in ELISA with antisera 
to the insect tachykinin-related peptide LomTK I and the frog 
tachykinin kassinin. Both isolated peptides were immunopositive 
in the LomTK ELISA and one of them in the kassinin ELISA. 
fhe two callitachykinins have the C-terminus in common: 
A-F-X-G-V-R-amide (where X represents Y or V). The N-ter- 
minus, however, differs significantly (Table 6). The C-terminus 
portion, F-X-G-V-R-amide, is also identical to the locustata- 
chykinins (33,34), indicating their relationship. The degree of 
homology between callitachykinin I and locustatachykinin I is 
67%. The recently identified invertebrate peptides urechistachy- 
kinin I and II (19) also display some degree of sequence identity 
to the callitachykinins and the locustatachykinins by the F-Xr  
G-Xz-R-amide in the C-terminus. As seen in Table 6, the sim- 
ilarities of the blowfly peptides to the vertebrate and cephalopod 
tachykinins and the mosquito sialokinins are less striking because 
the latter all have an F-X-G-L-M-amide C-terminal (X is either 
a Y, V, I, or an F). However, an interesting observation is that 
callitachykinin I shares the sequence F-Y-G with uperolein, scy- 
liorhinin, and the sialokinins, and callitachykinin II the sequence 
F-V-G with kassinin and neurokinin A (Table 6). Further support 
for the relation between the locustatachykinins, callitachykinins, 
and vertebrate tachykinins is that in several positions single nu- 
cleotide substitutions in the codons would yield peptides with 
additional homologous amino acids. Several neuropeptides seem 
to have the position 4 (counted from the C-terminus) variable 
and the other C-terminal amino acids constant. This composition 
is also seen in the insect myokinins, like leucokinins, which have 
a C-terminal core of F-X-S-W-G-amide (16,17) and the allato- 
statins with the C-terminus Y-X-F-G-L-amide (7,8). 
It could not be conclusively determined, at this stage of the 
investigation, whether the isolated peptides are neuropeptides 
or not, because an extract of whole flies was used for the isolation. 
However, the fact that the isolated peptides were recognized by 
the locustatachykinin and kassinin antisera in ELISA tests gives 
some clues about the distribution, because the same antisera 
recognize interneurons in the CNS and endocrine cells in the 
midgut of the blowfly in immunocytochemical experiments 
(24,25). Based on immunocytochemistry and immunochemistry, 
it was suggested that in the blowfly nervous system there are at 
least two tachykinin-related peptides, one resembling locusta- 
tachykinins and one sharing an epitope with kassinin (24,25). 
This could be confirmed in the present study in ELISAs of the 
natural and synthetic callitachykinins I and II. Immunocyto- 
chemical studies indicated that the two Calliphora peptides may 
be colocalized in the blowfly central nervous system (25), but 
cross-reactivity could not be ruled out. When region-specific 
antisera to callitachykinin I and II have been produced, it will 
be possible to more accurately determine the peptide localization 
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FIG. 3. ELISA tests on synthetic callitachykinin I and II. (A) Dilution series of LomTK I 
antiserum with 10 pmol peptide coated to the plate. (B) Dilution series of kassinin antiserum 
with I00 pmol peptide coated to the plate. Each test was performed in duplicate. The bars 
represent deviation from mean OD values. 
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TABLE 6 
AMINO ACID SEQUENCES OF CALLITACHYKININ I AND II 
IN COMPARISON TO VARIOUS TACHYKININS AND 
TACHYKININ-RELATED PEPTIDES 























Callitachykinin I in comparison to similar peptides 
Callitachykinin I A-P-T-A-F-Y-G-V-R This paper 
Locustatachykinin I G - P - S - G - F- Y - G - V - R 33 
Sialokinin 1 N-T-G-D-K-F-Y-G-L-M 2 
Uperolein pE- P-D-P-N-A-F-Y-G-  L-M 12 
Scyliorhinin I A-K-F-D-K-F-Y-G-L-M 5 
Eledoisin pE- P- S-K-D-A-F-  I -G-  L-M 11 
Callitachykinin II in comparison to similar peptides 














* Origin of peptides is as follows: eledoisin (cephalopod), kassinin and 
uperolein (amphibians), locustatachykinins and sialokinins (insects), 
neurokinins A and B, and substance P (mammals), scyliorhinin I (elas- 
mobranch), urechistachykinins (echiuroid worm). 
t All peptides are C-terminally amidated. 
by immunocytochemistry and to corroborate possible colocal- 
ization. 
The question whether the different peptides of  the tachykinin 
family of  each species have different functions and activate dif- 
ferent receptor types or not is highly interesting. Studies of  the 
mammal ian  nervous system have indicated the presence of  sev- 
eral forms of  tachykinin receptors and a multiplicity in tachy- 
kinin signaling (14,22). In another dipteran insect, Drosophila, 
two different putative tachykinin receptors have been demon- 
strated by recombinant  D N A  technique (23,26), suggesting that 
insects also operate with complex tachykinin-like systems. The 
Drosophila tachykinin receptor (NKD) cloned by Monnier  and 
coworkers (26) is a G-protein receptor complex displaying a 38% 
homology with a mammal ian  tachykinin receptor and responds 
specifically to locustatachykinin II when expressed. 
Immunocytochemical  studies of  the blowfly and Drosophila 
have indicated that antisera to substance P recognize a population 
of  neurons in the brain and ventral ganglia that is distinctly 
different from that detected with antisera to locustatachykinin 
I and kassinin (31,32). The recent discovery of  the siaiokinins I 
and II from salivary glands of  the mosquito Aedes aegypti (2) 
confirms the existence of  insect peptides with the C-terminus 
structure F-X-G-L-M-amide, characteristic of  vertebrate tachy- 
kinins (Table 6). The neuronal localization of  sialokinins has 
not yet been determined, but future work may answer the ques- 
tion whether the insect nervous system is utilizing two classes 
of  tachykinin-like peptides: those related to locustatachykinins 
and callitachykinins, and others with a C-terminus, like the ver- 
tebrate tachykinins and the sialokinins. 
In the blowfly, C. vomitoria, we now know the amino acid 
sequences of  peptides representing three different families: 
FMRFamide-related peptides (8), allatostatins (9), and the 
tachykinins shown in the present investigation. At least 20 dif- 
ferent peptide families have been indicated in various insects 
(18,29,35), and it is likely that members of  several additional 
families will be isolated from C. vomitoria in the future. 
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